世界の尿失禁治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Urinary Incontinence Treatment Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-6059
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、尿失禁治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（鎮痙薬、筋弛緩薬、α遮断薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・尿失禁治療薬の市場動向
・企業の競争状況、市場シェア
・尿失禁治療薬の種類別市場規模と予測2016-2027（鎮痙薬、筋弛緩薬、α遮断薬、その他）
・尿失禁治療薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局）
・尿失禁治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・尿失禁治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・尿失禁治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・尿失禁治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・尿失禁治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Johnson & Johnson、Pfizer Inc.、Astellas Pharma, Inc.、Allergan, Inc.、Takeda Pharmaceutical Company Limited、Merck & Co., Inc.、Sanofi S.A.）
・結論

Market Analysis and Insights: Global Urinary Incontinence Treatment Drugs Market
The global Urinary Incontinence Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Urinary Incontinence Treatment Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Urinary Incontinence Treatment Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Urinary Incontinence Treatment Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Urinary Incontinence Treatment Drugs market.

Global Urinary Incontinence Treatment Drugs Scope and Market Size
Urinary Incontinence Treatment Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Urinary Incontinence Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Distribution Channels in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antispasmodic Agents
Skeletal Muscle Relaxants
Alpha Blockers
Others

Segment by Distribution Channels
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Johnson & Johnson
Pfizer Inc.
Astellas Pharma, Inc.
Allergan, Inc.
Takeda Pharmaceutical Company Limited
Merck & Co., Inc.
Sanofi S.A.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Urinary Incontinence Treatment Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antispasmodic Agents
1.2.3 Skeletal Muscle Relaxants
1.2.4 Alpha Blockers
1.2.5 Others
1.3 Market by Application
1.3.1 Global Urinary Incontinence Treatment Drugs Market Share by Distribution Channels: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Urinary Incontinence Treatment Drugs Market Perspective (2016-2027)
2.2 Urinary Incontinence Treatment Drugs Growth Trends by Regions
2.2.1 Urinary Incontinence Treatment Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Urinary Incontinence Treatment Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Urinary Incontinence Treatment Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Urinary Incontinence Treatment Drugs Industry Dynamic
2.3.1 Urinary Incontinence Treatment Drugs Market Trends
2.3.2 Urinary Incontinence Treatment Drugs Market Drivers
2.3.3 Urinary Incontinence Treatment Drugs Market Challenges
2.3.4 Urinary Incontinence Treatment Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Urinary Incontinence Treatment Drugs Players by Revenue
3.1.1 Global Top Urinary Incontinence Treatment Drugs Players by Revenue (2016-2021)
3.1.2 Global Urinary Incontinence Treatment Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Urinary Incontinence Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Urinary Incontinence Treatment Drugs Revenue
3.4 Global Urinary Incontinence Treatment Drugs Market Concentration Ratio
3.4.1 Global Urinary Incontinence Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Urinary Incontinence Treatment Drugs Revenue in 2020
3.5 Urinary Incontinence Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Urinary Incontinence Treatment Drugs Product Solution and Service
3.7 Date of Enter into Urinary Incontinence Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Urinary Incontinence Treatment Drugs Breakdown Data by Type
4.1 Global Urinary Incontinence Treatment Drugs Historic Market Size by Type (2016-2021)
4.2 Global Urinary Incontinence Treatment Drugs Forecasted Market Size by Type (2022-2027)

5 Urinary Incontinence Treatment Drugs Breakdown Data by Distribution Channels
5.1 Global Urinary Incontinence Treatment Drugs Historic Market Size by Distribution Channels (2016-2021)
5.2 Global Urinary Incontinence Treatment Drugs Forecasted Market Size by Distribution Channels (2022-2027)

6 North America
6.1 North America Urinary Incontinence Treatment Drugs Market Size (2016-2027)
6.2 North America Urinary Incontinence Treatment Drugs Market Size by Type
6.2.1 North America Urinary Incontinence Treatment Drugs Market Size by Type (2016-2021)
6.2.2 North America Urinary Incontinence Treatment Drugs Market Size by Type (2022-2027)
6.2.3 North America Urinary Incontinence Treatment Drugs Market Size by Type (2016-2027)
6.3 North America Urinary Incontinence Treatment Drugs Market Size by Distribution Channels
6.3.1 North America Urinary Incontinence Treatment Drugs Market Size by Distribution Channels (2016-2021)
6.3.2 North America Urinary Incontinence Treatment Drugs Market Size by Distribution Channels (2022-2027)
6.3.3 North America Urinary Incontinence Treatment Drugs Market Size by Distribution Channels (2016-2027)
6.4 North America Urinary Incontinence Treatment Drugs Market Size by Country
6.4.1 North America Urinary Incontinence Treatment Drugs Market Size by Country (2016-2021)
6.4.2 North America Urinary Incontinence Treatment Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Urinary Incontinence Treatment Drugs Market Size (2016-2027)
7.2 Europe Urinary Incontinence Treatment Drugs Market Size by Type
7.2.1 Europe Urinary Incontinence Treatment Drugs Market Size by Type (2016-2021)
7.2.2 Europe Urinary Incontinence Treatment Drugs Market Size by Type (2022-2027)
7.2.3 Europe Urinary Incontinence Treatment Drugs Market Size by Type (2016-2027)
7.3 Europe Urinary Incontinence Treatment Drugs Market Size by Distribution Channels
7.3.1 Europe Urinary Incontinence Treatment Drugs Market Size by Distribution Channels (2016-2021)
7.3.2 Europe Urinary Incontinence Treatment Drugs Market Size by Distribution Channels (2022-2027)
7.3.3 Europe Urinary Incontinence Treatment Drugs Market Size by Distribution Channels (2016-2027)
7.4 Europe Urinary Incontinence Treatment Drugs Market Size by Country
7.4.1 Europe Urinary Incontinence Treatment Drugs Market Size by Country (2016-2021)
7.4.2 Europe Urinary Incontinence Treatment Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Urinary Incontinence Treatment Drugs Market Size (2016-2027)
8.2 Asia-Pacific Urinary Incontinence Treatment Drugs Market Size by Type
8.2.1 Asia-Pacific Urinary Incontinence Treatment Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Urinary Incontinence Treatment Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Urinary Incontinence Treatment Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Urinary Incontinence Treatment Drugs Market Size by Distribution Channels
8.3.1 Asia-Pacific Urinary Incontinence Treatment Drugs Market Size by Distribution Channels (2016-2021)
8.3.2 Asia-Pacific Urinary Incontinence Treatment Drugs Market Size by Distribution Channels (2022-2027)
8.3.3 Asia-Pacific Urinary Incontinence Treatment Drugs Market Size by Distribution Channels (2016-2027)
8.4 Asia-Pacific Urinary Incontinence Treatment Drugs Market Size by Region
8.4.1 Asia-Pacific Urinary Incontinence Treatment Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Urinary Incontinence Treatment Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Urinary Incontinence Treatment Drugs Market Size (2016-2027)
9.2 Latin America Urinary Incontinence Treatment Drugs Market Size by Type
9.2.1 Latin America Urinary Incontinence Treatment Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Urinary Incontinence Treatment Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Urinary Incontinence Treatment Drugs Market Size by Type (2016-2027)
9.3 Latin America Urinary Incontinence Treatment Drugs Market Size by Distribution Channels
9.3.1 Latin America Urinary Incontinence Treatment Drugs Market Size by Distribution Channels (2016-2021)
9.3.2 Latin America Urinary Incontinence Treatment Drugs Market Size by Distribution Channels (2022-2027)
9.3.3 Latin America Urinary Incontinence Treatment Drugs Market Size by Distribution Channels (2016-2027)
9.4 Latin America Urinary Incontinence Treatment Drugs Market Size by Country
9.4.1 Latin America Urinary Incontinence Treatment Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Urinary Incontinence Treatment Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Urinary Incontinence Treatment Drugs Market Size (2016-2027)
10.2 Middle East & Africa Urinary Incontinence Treatment Drugs Market Size by Type
10.2.1 Middle East & Africa Urinary Incontinence Treatment Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Urinary Incontinence Treatment Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Urinary Incontinence Treatment Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Urinary Incontinence Treatment Drugs Market Size by Distribution Channels
10.3.1 Middle East & Africa Urinary Incontinence Treatment Drugs Market Size by Distribution Channels (2016-2021)
10.3.2 Middle East & Africa Urinary Incontinence Treatment Drugs Market Size by Distribution Channels (2022-2027)
10.3.3 Middle East & Africa Urinary Incontinence Treatment Drugs Market Size by Distribution Channels (2016-2027)
10.4 Middle East & Africa Urinary Incontinence Treatment Drugs Market Size by Country
10.4.1 Middle East & Africa Urinary Incontinence Treatment Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Urinary Incontinence Treatment Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Urinary Incontinence Treatment Drugs Introduction
11.1.4 Johnson & Johnson Revenue in Urinary Incontinence Treatment Drugs Business (2016-2021)
11.1.5 Johnson & Johnson Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Details
11.2.2 Pfizer Inc. Business Overview
11.2.3 Pfizer Inc. Urinary Incontinence Treatment Drugs Introduction
11.2.4 Pfizer Inc. Revenue in Urinary Incontinence Treatment Drugs Business (2016-2021)
11.2.5 Pfizer Inc. Recent Development
11.3 Astellas Pharma, Inc.
11.3.1 Astellas Pharma, Inc. Company Details
11.3.2 Astellas Pharma, Inc. Business Overview
11.3.3 Astellas Pharma, Inc. Urinary Incontinence Treatment Drugs Introduction
11.3.4 Astellas Pharma, Inc. Revenue in Urinary Incontinence Treatment Drugs Business (2016-2021)
11.3.5 Astellas Pharma, Inc. Recent Development
11.4 Allergan, Inc.
11.4.1 Allergan, Inc. Company Details
11.4.2 Allergan, Inc. Business Overview
11.4.3 Allergan, Inc. Urinary Incontinence Treatment Drugs Introduction
11.4.4 Allergan, Inc. Revenue in Urinary Incontinence Treatment Drugs Business (2016-2021)
11.4.5 Allergan, Inc. Recent Development
11.5 Takeda Pharmaceutical Company Limited
11.5.1 Takeda Pharmaceutical Company Limited Company Details
11.5.2 Takeda Pharmaceutical Company Limited Business Overview
11.5.3 Takeda Pharmaceutical Company Limited Urinary Incontinence Treatment Drugs Introduction
11.5.4 Takeda Pharmaceutical Company Limited Revenue in Urinary Incontinence Treatment Drugs Business (2016-2021)
11.5.5 Takeda Pharmaceutical Company Limited Recent Development
11.6 Merck & Co., Inc.
11.6.1 Merck & Co., Inc. Company Details
11.6.2 Merck & Co., Inc. Business Overview
11.6.3 Merck & Co., Inc. Urinary Incontinence Treatment Drugs Introduction
11.6.4 Merck & Co., Inc. Revenue in Urinary Incontinence Treatment Drugs Business (2016-2021)
11.6.5 Merck & Co., Inc. Recent Development
11.7 Sanofi S.A.
11.7.1 Sanofi S.A. Company Details
11.7.2 Sanofi S.A. Business Overview
11.7.3 Sanofi S.A. Urinary Incontinence Treatment Drugs Introduction
11.7.4 Sanofi S.A. Revenue in Urinary Incontinence Treatment Drugs Business (2016-2021)
11.7.5 Sanofi S.A. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Urinary Incontinence Treatment Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antispasmodic Agents
Table 3. Key Players of Skeletal Muscle Relaxants
Table 4. Key Players of Alpha Blockers
Table 5. Key Players of Others
Table 6. Global Urinary Incontinence Treatment Drugs Market Size Growth by Distribution Channels (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Urinary Incontinence Treatment Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Urinary Incontinence Treatment Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Urinary Incontinence Treatment Drugs Market Share by Regions (2016-2021)
Table 10. Global Urinary Incontinence Treatment Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Urinary Incontinence Treatment Drugs Market Share by Regions (2022-2027)
Table 12. Urinary Incontinence Treatment Drugs Market Trends
Table 13. Urinary Incontinence Treatment Drugs Market Drivers
Table 14. Urinary Incontinence Treatment Drugs Market Challenges
Table 15. Urinary Incontinence Treatment Drugs Market Restraints
Table 16. Global Urinary Incontinence Treatment Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Urinary Incontinence Treatment Drugs Market Share by Players (2016-2021)
Table 18. Global Top Urinary Incontinence Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urinary Incontinence Treatment Drugs as of 2020)
Table 19. Ranking of Global Top Urinary Incontinence Treatment Drugs Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Urinary Incontinence Treatment Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Urinary Incontinence Treatment Drugs Product Solution and Service
Table 23. Date of Enter into Urinary Incontinence Treatment Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Urinary Incontinence Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Urinary Incontinence Treatment Drugs Revenue Market Share by Type (2016-2021)
Table 27. Global Urinary Incontinence Treatment Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Urinary Incontinence Treatment Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Urinary Incontinence Treatment Drugs Market Size Share by Distribution Channels (2016-2021) & (US$ Million)
Table 30. Global Urinary Incontinence Treatment Drugs Revenue Market Share by Distribution Channels (2016-2021)
Table 31. Global Urinary Incontinence Treatment Drugs Forecasted Market Size by Distribution Channels (2022-2027) (US$ Million)
Table 32. Global Urinary Incontinence Treatment Drugs Revenue Market Share by Distribution Channels (2022-2027) & (US$ Million)
Table 33. North America Urinary Incontinence Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Urinary Incontinence Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Urinary Incontinence Treatment Drugs Market Size by Distribution Channels (2016-2021) (US$ Million)
Table 36. North America Urinary Incontinence Treatment Drugs Market Size by Distribution Channels (2022-2027) & (US$ Million)
Table 37. North America Urinary Incontinence Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Urinary Incontinence Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Urinary Incontinence Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Urinary Incontinence Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Urinary Incontinence Treatment Drugs Market Size by Distribution Channels (2016-2021) (US$ Million)
Table 42. Europe Urinary Incontinence Treatment Drugs Market Size by Distribution Channels (2022-2027) & (US$ Million)
Table 43. Europe Urinary Incontinence Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Urinary Incontinence Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Urinary Incontinence Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Urinary Incontinence Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Urinary Incontinence Treatment Drugs Market Size by Distribution Channels (2016-2021) (US$ Million)
Table 48. Asia-Pacific Urinary Incontinence Treatment Drugs Market Size by Distribution Channels (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Urinary Incontinence Treatment Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Urinary Incontinence Treatment Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Urinary Incontinence Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Urinary Incontinence Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Urinary Incontinence Treatment Drugs Market Size by Distribution Channels (2016-2021) (US$ Million)
Table 54. Latin America Urinary Incontinence Treatment Drugs Market Size by Distribution Channels (2022-2027) & (US$ Million)
Table 55. Latin America Urinary Incontinence Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Urinary Incontinence Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Urinary Incontinence Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Urinary Incontinence Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Urinary Incontinence Treatment Drugs Market Size by Distribution Channels (2016-2021) (US$ Million)
Table 60. Middle East & Africa Urinary Incontinence Treatment Drugs Market Size by Distribution Channels (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Urinary Incontinence Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Urinary Incontinence Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 63. Johnson & Johnson Company Details
Table 64. Johnson & Johnson Business Overview
Table 65. Johnson & Johnson Urinary Incontinence Treatment Drugs Product
Table 66. Johnson & Johnson Revenue in Urinary Incontinence Treatment Drugs Business (2016-2021) & (US$ Million)
Table 67. Johnson & Johnson Recent Development
Table 68. Pfizer Inc. Company Details
Table 69. Pfizer Inc. Business Overview
Table 70. Pfizer Inc. Urinary Incontinence Treatment Drugs Product
Table 71. Pfizer Inc. Revenue in Urinary Incontinence Treatment Drugs Business (2016-2021) & (US$ Million)
Table 72. Pfizer Inc. Recent Development
Table 73. Astellas Pharma, Inc. Company Details
Table 74. Astellas Pharma, Inc. Business Overview
Table 75. Astellas Pharma, Inc. Urinary Incontinence Treatment Drugs Product
Table 76. Astellas Pharma, Inc. Revenue in Urinary Incontinence Treatment Drugs Business (2016-2021) & (US$ Million)
Table 77. Astellas Pharma, Inc. Recent Development
Table 78. Allergan, Inc. Company Details
Table 79. Allergan, Inc. Business Overview
Table 80. Allergan, Inc. Urinary Incontinence Treatment Drugs Product
Table 81. Allergan, Inc. Revenue in Urinary Incontinence Treatment Drugs Business (2016-2021) & (US$ Million)
Table 82. Allergan, Inc. Recent Development
Table 83. Takeda Pharmaceutical Company Limited Company Details
Table 84. Takeda Pharmaceutical Company Limited Business Overview
Table 85. Takeda Pharmaceutical Company Limited Urinary Incontinence Treatment Drugs Product
Table 86. Takeda Pharmaceutical Company Limited Revenue in Urinary Incontinence Treatment Drugs Business (2016-2021) & (US$ Million)
Table 87. Takeda Pharmaceutical Company Limited Recent Development
Table 88. Merck & Co., Inc. Company Details
Table 89. Merck & Co., Inc. Business Overview
Table 90. Merck & Co., Inc. Urinary Incontinence Treatment Drugs Product
Table 91. Merck & Co., Inc. Revenue in Urinary Incontinence Treatment Drugs Business (2016-2021) & (US$ Million)
Table 92. Merck & Co., Inc. Recent Development
Table 93. Sanofi S.A. Company Details
Table 94. Sanofi S.A. Business Overview
Table 95. Sanofi S.A. Urinary Incontinence Treatment Drugs Product
Table 96. Sanofi S.A. Revenue in Urinary Incontinence Treatment Drugs Business (2016-2021) & (US$ Million)
Table 97. Sanofi S.A. Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Urinary Incontinence Treatment Drugs Market Share by Type: 2020 VS 2027
Figure 2. Antispasmodic Agents Features
Figure 3. Skeletal Muscle Relaxants Features
Figure 4. Alpha Blockers Features
Figure 5. Others Features
Figure 6. Global Urinary Incontinence Treatment Drugs Market Share by Distribution Channels: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Urinary Incontinence Treatment Drugs Report Years Considered
Figure 11. Global Urinary Incontinence Treatment Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Urinary Incontinence Treatment Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Urinary Incontinence Treatment Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Urinary Incontinence Treatment Drugs Market Share by Regions (2022-2027)
Figure 15. Global Urinary Incontinence Treatment Drugs Market Share by Players in 2020
Figure 16. Global Top Urinary Incontinence Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urinary Incontinence Treatment Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Urinary Incontinence Treatment Drugs Revenue in 2020
Figure 18. Global Urinary Incontinence Treatment Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Urinary Incontinence Treatment Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Urinary Incontinence Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Urinary Incontinence Treatment Drugs Market Share by Type (2016-2027)
Figure 22. North America Urinary Incontinence Treatment Drugs Market Share by Distribution Channels (2016-2027)
Figure 23. North America Urinary Incontinence Treatment Drugs Market Share by Country (2016-2027)
Figure 24. United States Urinary Incontinence Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Urinary Incontinence Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Urinary Incontinence Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Urinary Incontinence Treatment Drugs Market Share by Type (2016-2027)
Figure 28. Europe Urinary Incontinence Treatment Drugs Market Share by Distribution Channels (2016-2027)
Figure 29. Europe Urinary Incontinence Treatment Drugs Market Share by Country (2016-2027)
Figure 30. Germany Urinary Incontinence Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Urinary Incontinence Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Urinary Incontinence Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Urinary Incontinence Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Urinary Incontinence Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Urinary Incontinence Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Urinary Incontinence Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Urinary Incontinence Treatment Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Urinary Incontinence Treatment Drugs Market Share by Distribution Channels (2016-2027)
Figure 39. Asia-Pacific Urinary Incontinence Treatment Drugs Market Share by Region (2016-2027)
Figure 40. China Urinary Incontinence Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Urinary Incontinence Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Urinary Incontinence Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Urinary Incontinence Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Urinary Incontinence Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Urinary Incontinence Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Urinary Incontinence Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Urinary Incontinence Treatment Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Urinary Incontinence Treatment Drugs Market Share by Distribution Channels (2016-2027)
Figure 49. Latin America Urinary Incontinence Treatment Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Urinary Incontinence Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Urinary Incontinence Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Urinary Incontinence Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Urinary Incontinence Treatment Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Urinary Incontinence Treatment Drugs Market Share by Distribution Channels (2016-2027)
Figure 55. Middle East & Africa Urinary Incontinence Treatment Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Urinary Incontinence Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Urinary Incontinence Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Urinary Incontinence Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Johnson & Johnson Revenue Growth Rate in Urinary Incontinence Treatment Drugs Business (2016-2021)
Figure 60. Pfizer Inc. Revenue Growth Rate in Urinary Incontinence Treatment Drugs Business (2016-2021)
Figure 61. Astellas Pharma, Inc. Revenue Growth Rate in Urinary Incontinence Treatment Drugs Business (2016-2021)
Figure 62. Allergan, Inc. Revenue Growth Rate in Urinary Incontinence Treatment Drugs Business (2016-2021)
Figure 63. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Urinary Incontinence Treatment Drugs Business (2016-2021)
Figure 64. Merck & Co., Inc. Revenue Growth Rate in Urinary Incontinence Treatment Drugs Business (2016-2021)
Figure 65. Sanofi S.A. Revenue Growth Rate in Urinary Incontinence Treatment Drugs Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

以下、関連資料のご紹介

世界のウイルス性肺炎治療薬市場規模・現状・予測（2021年-2027年）

Global Viral Pneumonia Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5025 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、ウイルス性肺炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（リバビリン、アシクロビル、ガンシクロビル、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模...

世界の多発性嚢胞腎治療薬市場規模・現状・予測（2021年-2027年）

Global Polycystic Kidney Disease Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4730 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、多発性嚢胞腎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ANG-3070、CIM-2、CR-8、その他）、用途別市場規模（常染色体優性多発性嚢胞腎（ADPKD）、常染色体劣性多発性嚢胞腎（A...

世界の副鼻腔炎治療薬市場規模・現状・予測（2021年-2027年）

Global Sinusitis Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6007 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、副鼻腔炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、NSAIDS、充血除去剤・粘液溶解剤、鼻洗浄キット）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界の勃起不全治療薬市場規模・現状・予測（2021年-2027年）

Global Erectile Dysfunction Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5727 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、勃起不全治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ホスホジエステラーゼ5型阻害剤、プロスタグランジンE1）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界の遅発性ジスキネジア(TD)治療薬市場規模・現状・予測（2021年-2027年）

Global Tardive Dyskinesia (TD) Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6032 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、遅発性ジスキネジア(TD)治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バルベナジン、デュテトラベナジン）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の糖尿病治療薬市場規模・現状・予測（2021年-2027年）

Global Diabetes Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5701 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、糖尿病治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、GLP-1、インスリン）、用途別市場規模（1型糖尿病、2型糖尿病）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の先天性インスリン過剰症治療薬市場規模・現状・予測（2021年-2027年）

Global Congenital Hyperinsulinism Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5672 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、先天性インスリン過剰症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ジアゾキシド、オクトレオチド、グルカゴン）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界の不眠症治療薬市場規模・現状・予測（2021年-2027年）

Global Insomnia Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5803 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、不眠症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（処方箋睡眠補助薬、店頭販売（OTC）睡眠補助薬）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界の生殖器ヘルペス治療薬市場規模・現状・予測（2021年-2027年）

Global Genital Herpes Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5752 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、生殖器ヘルペス治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アシクロビル、ファムシクロビル、バラシクロビル）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界の多発性硬化症薬物治療市場規模・現状・予測（2021年-2027年）

Global Multiple Sclerosis Drugs Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4534 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、多発性硬化症薬物治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（インターフェロン、免疫調節剤、免疫抑制剤）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（北米、...

世界のウイルス性肺炎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Viral Pneumonia Treatment Drugs Market The global Viral Pneumonia Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…
世界の羊膜感染症治療市場規模・現状・予測（2021年-2027年） Intra-amniotic infection is a common occurrence in pregnant women, which affects both the mother and baby. Intra-amniotic infection is also known as chorioamnionitis. The incidence is high at lower gestational ages. Market Analysis and Insights: Global Intra-amniotic Infection Treatment Market The …
世界のβ-ラクタム系薬剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Beta-Lactam Drugs Market The global Beta-Lactam Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a…
世界の移植治療薬市場規模・現状・予測（2021年-2027年） Transplantation is the transfer (engraftment) of human cells, tissues, or organs from a donor to a recipient, with the aim of restoring function(s) in the body. Market Analysis and Insights: Global Transplantation Therapeutics Drugs Market The global Transplantation Therapeutics Drugs market size is…
世界の高分子注射薬市場規模・現状・予測（2021年-2027年） Large molecules (biologics), also called biopharmaceuticals, are a type of drugs. These are based on proteins which have a therapeutic effect. Market Analysis and Insights: Global Large Molecule Injectable Drugs Market The global Large Molecule Injectable Drugs market size is projected to reach US$ …